Marta Reyman

Marta Reyman serves as a Researcher within the Department of Dermatology at Erasmus MC in Rotterdam, the Netherlands. Her academic profile highlights active engagement in interdisciplinary research at the intersection of dermatology, immunology, and microbiome science. Although dermatology is her departmental affiliation, her research extends into gastrointestinal immunology and vaccine development, reflecting the complex connections between skin and gut immunity.

Dr. Reyman's primary research interests lie in Immunology and Microbiology, with a specialized focus on Vaccinology and Microbiome Research. She investigates how the composition of the intestinal microbiota, particularly the presence of Escherichia coli and Bifidobacterium, influences the maturation of the immune system and the efficacy of vaccinations. Her work explores critical questions regarding the impact of early-life microbial exposure on long-term immune health, including the role of delivery mode (vaginal versus cesarean) in shaping the infant gut microbiome and subsequent vaccine responses.

Her most recent publication in Nature Communications (2022) demonstrated that the mode of delivery significantly modulates the intestinal microbiota, which in turn affects the antibody response to vaccinations. This research underscores the importance of the gut-immune axis in vaccine immunogenicity and opens avenues for microbiome-targeted interventions to improve vaccine efficacy, especially in vulnerable populations such as infants.

No scientific awards or major honors were documented in the available profile information.

Information regarding student supervision, research grants, or leadership of laboratory teams was not provided in the source material. However, her collaborative network, as indicated by her co-authorship on high-impact publications, suggests active engagement with multidisciplinary research groups in immunology and microbiome science.